A5040956880- Advanced Glycation End Products research
- Immune responses and vaccinations
- Food Security and Health in Diverse Populations
- Clostridium difficile and Clostridium perfringens research
- Natural Antidiabetic Agents Studies
- Inflammasome and immune disorders
- Microbial Metabolism and Applications
- Immune Cell Function and Interaction
- Antimicrobial Resistance in Staphylococcus
- Gut microbiota and health
- Tea Polyphenols and Effects
University of California, Berkeley
2024-2025
University of Florida
2021
Abstract Background Infection with the COVID-19-causing pathogen SARS-CoV-2 is associated disruption in human gut microbiome. The microbiome enables protection against diverse pathogens and exhibits dysbiosis during infectious autoimmune disease. Studies based United States China have found that severe COVID-19 cases altered composition when compared to mild cases. We present first study investigate of a population from Sub-Saharan Africa. Given impact geography cultural traditions on...
Background: Infection with the COVID-19-causing pathogen SARS-CoV-2 is associated disruption in human gut microbiome. The microbiome enables protection against diverse pathogens and exhibits dysbiosis during infectious autoimmune disease. Studies based United States China have found that severe COVID-19 cases altered composition when compared to mild cases. We present first study investigate of a population from Sub-Saharan Africa. Given impact geography cultural traditions on composition,...
Abstract Infected macrophages transition into aerobic glycolysis, a metabolic program crucial for control of bacterial infection. However, antimicrobial mechanisms supported by glycolysis are unclear. Methylglyoxal is highly toxic aldehyde that modifies proteins and DNA produced as side-product glycolysis. Here we show despite the toxicity this aldehyde, infected generate high levels methylglyoxal during while downregulating detoxification system. We use targeted mutations in mice to...